BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34724029)

  • 1. Nationwide Prevalence and Genotype Distribution of High-Risk Human Papillomavirus Infection in China.
    Zeng Z; Austin RM; Wang L; Guo X; Zeng Q; Zheng B; Zhao C
    Am J Clin Pathol; 2022 May; 157(5):718-723. PubMed ID: 34724029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPV prevalence and genotype distribution among women in Shandong Province, China: Analysis of 94,489 HPV genotyping results from Shandong's largest independent pathology laboratory.
    Jiang L; Tian X; Peng D; Zhang L; Xie F; Bi C; Wang R; Wang J; Qi D
    PLoS One; 2019; 14(1):e0210311. PubMed ID: 30653566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China.
    Wang R; Guo XL; Wisman GB; Schuuring E; Wang WF; Zeng ZY; Zhu H; Wu SW
    BMC Infect Dis; 2015 Jul; 15():257. PubMed ID: 26142044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
    Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of high-risk HPV genotyping in women with high-grade cervical lesions: evidence for improving the cervical cancer screening strategy in China.
    Xu H; Lin A; Shao X; Shi W; Zhang Y; Yan W
    Oncotarget; 2016 Dec; 7(50):83775-83783. PubMed ID: 27626178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prior high-risk HPV testing and Pap test results for 427 invasive cervical cancers in China's largest CAP-certified laboratory.
    Zheng B; Li Z; Griffith CC; Yan S; Chen C; Ding X; Liang X; Yang H; Zhao C
    Cancer Cytopathol; 2015 Jul; 123(7):428-34. PubMed ID: 25954852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-risk Human Papillomavirus Infection in Putian, China: A Cross-sectional Analysis of 98085 Women.
    Zhang R; Hong G; Liao C; Chen Z; Lin H; Yu L
    J Coll Physicians Surg Pak; 2023 Jun; 33(6):642-646. PubMed ID: 37300259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotype distribution of cervical HPV among Caribbean women in a population-based study in Martinique: The DEPIPAPUFR study.
    Najioullah F; Dorival MJ; Joachim C; Dispagne C; Macni J; Abel S; Sulpicy C; Charpentier-Baltide H; Sainte-Rose D; Salomon-Frechou B; Dieye M; Véronique-Baudin J; Pré M; Marquet M; Wan-Ajouhu G; Janky E; Riethmuller D; Cesaire R;
    PLoS One; 2021; 16(10):e0257915. PubMed ID: 34618835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensive HPV Genotyping Reveals High Association between Multiple Infections and Cervical Lesions in Chinese Women.
    Zhong F; Yu T; Ma X; Wang S; Cong Q; Tao X
    Dis Markers; 2022; 2022():8130373. PubMed ID: 35722626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Prevalence of High-Risk Human Papillomavirus in Hungary-A Geographically Representative, Cross-Sectional Study.
    Fogarasi AI; Benczik M; Moravcsik-Kornyicki Á; Kocsis A; Gyulai A; Kósa Z
    Pathol Oncol Res; 2022; 28():1610424. PubMed ID: 35783359
    [No Abstract]   [Full Text] [Related]  

  • 11. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
    Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
    Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of genital high-risk human papillomavirus infections and associated factors among women living with human immunodeficiency virus in Uganda.
    Nakigozi H; Ndejjo R; Bazeyo W; Nabaggala A; Achola C; Iga M; Kalyesubula S; Kanamwangi B; Mutungi G; Batte C; Mukunya D; Sserwanga L; Gemageine G; Oyoo CA; Nabadda S
    BMC Cancer; 2024 Feb; 24(1):243. PubMed ID: 38383366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPV genotyping linear assay test comparison in cervical cancer patients: implications for HPV prevalence and molecular epidemiology in a limited-resource area in Bandung, Indonesia.
    Panigoro R; Susanto H; Novel SS; Hartini S; Sahiratmadja E
    Asian Pac J Cancer Prev; 2013; 14(10):5843-7. PubMed ID: 24289587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymerase Chain Reaction Human Papillomavirus (HPV) Detection and HPV Genotyping in Invasive Cervical Cancers With Prior Negative HC2 Test Results.
    Tao X; Zheng B; Yin F; Zeng Z; Li Z; Griffith CC; Luo B; Ding X; Zhou X; Zhao C
    Am J Clin Pathol; 2017 May; 147(5):477-483. PubMed ID: 28340235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of abnormal cervical smears in a hospital cohort of French women beyond the upper age limit screening program.
    Luquain A; Belglaiaa E; Guenat D; Vrecko S; Riethmuller D; Valmary-Degano S; Bedgedjian I; Chouham S; Prétet JL; Mougin C
    Prev Med; 2015 Dec; 81():157-62. PubMed ID: 26348451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Independent risk factors for high-risk human papillomavirus infection among rural women in Shanxi Province, China: a population-based, case-control study.
    Shi R; Qi W; Cai J; Zhao M; Wang Z
    Arch Gynecol Obstet; 2023 Aug; 308(2):551-559. PubMed ID: 36814027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the Roche Linear Array HPV Genotyping Test within the VALGENT framework.
    Xu L; Oštrbenk A; Poljak M; Arbyn M
    J Clin Virol; 2018 Jan; 98():37-42. PubMed ID: 29241150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of human papillomavirus prevalence and infection patterns among women aged 25-64 according to age groups and cytology results in Ordos City, China.
    Wang S; Liu S; Tan S; Yin J; Li Y; Zhao F; Qiao Y
    Virol J; 2024 Jan; 21(1):12. PubMed ID: 38191450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of High-Risk Human Papillomavirus by RNA Assay in Home Self-Collected Samples Among Underscreened People in North Carolina.
    Lee F; Bukowski A; Spees LP; Wheeler SB; Brewer NT; Sanusi B; Hudgens MG; Jackson S; Barclay L; Carter A; Tang JH; Smith JS
    Sex Transm Dis; 2022 Mar; 49(3):244-249. PubMed ID: 34535615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Human Papillomavirus (HPV) Genotypes among Women During 2015-2020 in Mashhad, Iran.
    Bakhshani A; Ganjali R; Tabatabaeizadeh SE
    Arch Iran Med; 2023 Aug; 26(8):419-426. PubMed ID: 38301103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.